Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PSTV
Stock Latest News
Company Announcements
Plus Therapeutics Updates Executive Compensation, Approves 2025 Bonuses
1d ago
8K
PSTV
Premium
The Fly
Plus Therapeutics initiated with a Buy at Lake Street
12d ago
PSTV
Premium
The Fly
Plus Therapeutics price target lowered to $1.50 from $3 at Maxim
23d ago
PSTV
Premium
Ratings
Plus Therapeutics: Underpenetrated CNSide Commercial Potential and Reyobiq Accelerated-Approval Upside Support Buy Rating into 2026
23d ago
PSTV
Premium
The Fly
Plus Therapeutics price target lowered to $1 from $2 at H.C. Wainwright
23d ago
PSTV
Premium
Company Announcements
Plus Therapeutics Sharpens Focus on CNS Cancer Strategy
24d ago
8K
PSTV
Premium
The Fly
Plus Therapeutics announces anticipated milestones for FY26
24d ago
PSTV
Premium
Company Announcements
Plus Therapeutics completes underwritten public equity offering
29d ago
8K
PSTV
Premium
The Fly
Plus Therapeutics prices 39.5M units at 38c in upsized public offering
1M ago
PSTV
Premium
The Fly
Plus Therapeutics files to sell 22.32M units
1M ago
PSTV
Premium
The Fly
Plus announces completion of Type B meeting with U.S. FDA for REYOBIQ
1M ago
PSTV
Premium
Ratings
Buy Rating for Plus Therapeutics: Strategic Advancements and Promising Developments in CNSide Diagnostics and LM Program
2M ago
PSTV
Premium
The Fly
Plus Therapeutics expands CNSide assay platform to State of California
2M ago
PSTV
Premium
The Fly
Plus Therapeutics announces expansion of CNSide Team
2M ago
PSTV
Premium
The Fly
Plus Therapeutics presents REYOBIQ data at WFNOS/SNO annual meeting
2M ago
PSTV
Premium
Ratings
Strategic Advancements and Market Expansion Drive Plus Therapeutics’ Buy Rating
3M ago
PSTV
Premium
The Fly
Plus Therapeutics completes FDA meeting on REYOBIQ development plans
3M ago
PSTV
Premium
Ratings
Strategic Advancements and Expanding Coverage Propel Plus Therapeutics’ Growth Potential
3M ago
PSTV
Premium
The Fly
Plus Therapeutics’ assay secures national coverage agreement with Humana
3M ago
HUM
PSTV
Premium
Company Announcements
Plus Therapeutics Gains Nasdaq Extension for Compliance
3M ago
8K
PSTV
Premium
The Fly
Plus receives additional extension to regain compliance with Nasdasq
3M ago
PSTV
Premium
The Fly
Plus Therapeutics highlights ReSPECT-LM trial results at SITC meeting
3M ago
PSTV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
